Doctors on Demand Surpasses 1 Million Consultations with Sustained Profitability

Scaling Telehealth Amid Market Expansion

Vitura Health Limited’s (ASX:VIT) telehealth platform, Doctors on Demand (DoD), has crossed the 1 million consultations mark since the start of FY2024, underscoring the rapid scale and utilisation of its virtual GP service. Acquired in October 2023, DoD now operates as a 24/7 primary care telehealth provider, enabling patients to access face-to-face consultations online for a broad range of health needs.

Revenue growth has been striking. From $14.1 million in the first three quarters of FY2024, DoD’s revenue climbed to $21.6 million in the same period of FY2026, a 54% uplift reflecting robust demand and Vitura’s operational execution. This growth is particularly notable given the company’s simultaneous 4% reduction in operational expenditure, driving a 14% efficiency gain.

From Losses to Sustainable Profitability

DoD’s financial trajectory has shifted markedly. EBITDA margins improved from a negative 3% in FY2024 to 5% in FY2026 Q1-Q3, signalling a transition to sustainable profitability. Vitura’s Chief Revenue Officer Ryan Tattle highlighted that DoD not only achieved positive operating cash flow but also delivered EBITDA profitability ahead of initial expectations, a testament to disciplined integration and growth strategy.

The platform’s gross margin remains stable and predictable, supported by a mix of B2C and B2B patients, including referrals from private health insurers. This diversification enhances revenue resilience and positions DoD as a key profit contributor within Vitura’s broader digital health portfolio.

Expanding Doctor Network and Consultation Volumes

Alongside financial gains, the number of qualified doctors on DoD’s platform has surged from around 200 at acquisition to over 320 as of April 2026. These practitioners use the platform as a primary or secondary income source, reflecting both improved retention and ongoing onboarding aligned with patient growth. Consultation volumes have risen accordingly, with daily consultation records increasing from 1,039 in FY2024 to 1,539 in FY2026.

This expansion occurs as Australian patients increasingly adopt telehealth for convenience and quality care, a trend Vitura aims to leverage further by integrating DoD with its General and Specialty Clinic patient base, potentially unlocking additional revenue streams in FY2027.

Strategic Positioning in a Diversifying Digital Health Business

DoD’s progress comes amid Vitura’s broader transformation, including recent leadership changes such as the appointment of Justin James as CEO, who brings expertise in specialty therapies and digital health growth strategies. This leadership shift, detailed in a recent announcement, aligns with Vitura’s ambition to deepen its footprint across telehealth, medicinal cannabis, and emerging psychedelic-assisted therapies.

While Vitura’s medicinal cannabis segment has faced margin pressures and posted losses in recent results, the telehealth platform’s profitability offers a counterbalance and diversification. Vitura’s integration of multiple digital health services, including telehealth clinics, cannabis distribution via Canview, and psychedelic research ventures, positions it uniquely within Australia’s evolving healthcare landscape.